COMMUNIQUÉS West-GlobeNewswire

NeurAxis Expands Payer Coverage with New Policies
04/08/2026
CARMEL, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
04/08/2026
NASHVILLE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report second quarter 2026 financial results after the market closes on Monday [...]
Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases
04/08/2026
-- First-in-human trial of LBL-051 is enrolling patients with refractory autoimmune diseases to rapidly generate broad proof of concept -- Cambridge, Mass., August 4, 2026 - Oblenio Bio (“Oblenio” or “the Company”) [...]
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
04/08/2026
Partnership brings Nociscan for chronic low back pain to one of the nation's leading neurosurgery and spine care networks Goodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training [...]
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
04/08/2026
-- -11.6% mean reduction in BMI from baseline at Week 16 (n=7) -- -- BMI reductions consistent with setmelanotide and bivamelagon -- -- Management to host conference call to discuss second quarter 2026 financial results [...]
Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader
04/08/2026
Oral STAT6 degrader advances into clinical development for type 2 inflammatory diseases Nurix has earned approximately $139 million to date under its collaboration with Sanofi and remains eligible to receive [...]
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
04/08/2026
WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Average Patients Increased 450 to 8,950; Reiterates 2026 WAKIX Net Revenue Guidance of $1.0 Billion to $1.04 Billion Phase [...]
ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models
04/08/2026
Annual ABBYY Ascend Developer Conference showcased the power of enterprises using a hybrid AI approach AUSTIN, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced SlateWorks Global Solutions (Slateworks) was [...]
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
04/08/2026
Lisata has filed suit against Kuva Labs Inc. and its subsidiary seeking, among other things, damages for the benefit of its stockholders Lisata’s Board of Directors and management continues to evaluate strategic [...]
Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
04/08/2026
MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced [...]
Certara Reports Second Quarter 2026 Financial Results
04/08/2026
A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance [...]
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
04/08/2026
FOSTER CITY, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection
04/08/2026
Haute Couture evening gown constructed using AMSilk-blend fabric Follows debut of AMSilk bioengineered silk protein yarns in Balenciaga Spring Collection 2026 NEURIED, Germany, Aug. 04, 2026 (GLOBE NEWSWIRE) -- AMSilk, [...]
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
04/08/2026
Leiden, the Netherlands, August 4, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR), today announced its participation in the Canaccord Genuity 46 th Annual Growth Conference in Boston on August 12-13 [...]
Transactions in connection with share buy-back program
04/08/2026
Company announcement no. 28 - 26 04 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech
04/08/2026
Growing recognition across leading international business media highlights increasing interest in the convergence of artificial intelligence, personalized wellness and digital health. LONDON, Aug. 03, 2026 (GLOBE [...]
Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques
04/08/2026
MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques Paris, le 4 août 2026. Sanofi a annoncé aujourd’hui que la [...]

Pages